diffquick® staining set (Medion Diagnostics)
90
Structured Review
Medion Diagnostics
diffquick® staining set
Diffquick® Staining Set, supplied by Medion Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/diffquick%C2%AE+staining+set/diffquick+staining+kit/pm31531741-84-14-17
Average 90 stars, based on 1 article reviews
Diffquick® Staining Set, supplied by Medion Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/diffquick%C2%AE+staining+set/diffquick+staining+kit/pm31531741-84-14-17
Average 90 stars, based on 1 article reviews
diffquick® staining set - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Membrane:Article Title: Inhibition of bone morphogenetic protein signaling reduces viability, growth and migratory potential of non-small cell lung carcinoma cells. Article Snippet: Purpose BMP signaling has an oncogenic and tumor-suppressing activity in lung cancer that makes the prospective therapeutic utility of BMP signaling in lung cancer treatment complex.. A more in-depth analysis of lung cancer subtypes is needed to identify BMP-related therapeutic targets.. We sought to examine the influence of BMP signaling on the viability, growth and migration properties of the cell line LCLC-103H, which originates from a large cell lung carcinoma with giant cells and an extended aneuploidy. Staining:Article Title: Inhibition of bone morphogenetic protein signaling reduces viability, growth and migratory potential of non-small cell lung carcinoma cells. Article Snippet: Purpose BMP signaling has an oncogenic and tumor-suppressing activity in lung cancer that makes the prospective therapeutic utility of BMP signaling in lung cancer treatment complex.. A more in-depth analysis of lung cancer subtypes is needed to identify BMP-related therapeutic targets.. We sought to examine the influence of BMP signaling on the viability, growth and migration properties of the cell line LCLC-103H, which originates from a large cell lung carcinoma with giant cells and an extended aneuploidy. Microscopy:Article Title: Inhibition of bone morphogenetic protein signaling reduces viability, growth and migratory potential of non-small cell lung carcinoma cells. Article Snippet: Purpose BMP signaling has an oncogenic and tumor-suppressing activity in lung cancer that makes the prospective therapeutic utility of BMP signaling in lung cancer treatment complex.. A more in-depth analysis of lung cancer subtypes is needed to identify BMP-related therapeutic targets.. We sought to examine the influence of BMP signaling on the viability, growth and migration properties of the cell line LCLC-103H, which originates from a large cell lung carcinoma with giant cells and an extended aneuploidy. |